JUN 15, 2017 6:58 PM PDT

One Molecule at the Pinnacle of Gut Health

WRITTEN BY: Kara Marker

Expression of a gene called gp96 has been discovered as vital for the training of T cells, educating these immune fighters to tell the difference between harmful cells like bacteria and viruses and healthy cells, like host cells and food particles. For a healthy gut, this distinction is paramount. 

The story begins with another component of the immune system, cells called professional antigen-presenting cells (pAPCs), which are charged with the important task of training T cells. Antigens are a sort of code that cells express to signal whether they are “good’ or “bad.” pAPCs use a class of proteins called toll-like receptors (TLRs) to camp out on the cell surface and recognize antigens floating by. When an antigen is spotted, pAPCs take advantage of a training opportunity for T cells, showing them how to recognize an antigen.

Here, T cells are conditioned to either target and attack antigens from dangerous pathogens or be tolerant and leave alone harmless agents. The cells responsible for these results are either inflammatory pAPCs or tolerogenic pAPCs, respectively.

From the Medical University of South Carolina, scientists conducted a study to identify the gene gp96 and its role in the training process. The study, published in the journal Scientific Reports, is the first to investigate gp96 as involved in gut homeostasis.

Gp96 is a molecule known to be required for healthy gut function. In the gut, cells must know how to leave alone the healthy bacteria and food particles but attack any dangerous invaders. Therefore, a balance between inflammatory and tolerant T cells, or inflammatory and tolerogenic pAPCs, is very important. In the case of colitis, an inflammatory reaction in the gut, the ratio between inflammatory and tolerant T cells is way out of balance.

Using a genetically altered mouse model that lacked gp96 expression, researchers quickly observed that without the gene’s activity, there is the same imbalanced ratio that leads to colitis. Researchers involved in the experiment believe that a variety of molecular consequences, including pAPCs being less able to travel to the the lymph nodes and less able to recognize antigens, are to blame for this reaction. However, further study is needed to connect the loss of gp96 to the development of human colitis.

"This study shines a light on the pathogenesis of inflammatory bowel disease and offers a positive impact on its future clinical management," explained the senior author of the study, Bei Liu, MD.

Source: Medical University of South Carolina

About the Author
  • I am a scientific journalist and enthusiast, especially in the realm of biomedicine. I am passionate about conveying the truth in scientific phenomena and subsequently improving health and public awareness. Sometimes scientific research needs a translator to effectively communicate the scientific jargon present in significant findings. I plan to be that translating communicator, and I hope to decrease the spread of misrepresented scientific phenomena! Check out my science blog: ScienceKara.com.
You May Also Like
NOV 13, 2019
Health & Medicine
NOV 13, 2019
Antibiotic Resistance by the Numbers
The Centers for Disease Control and Prevention (CDC) just released its latest Antibiotic Threats in the United States report, which is summarized in the vi...
NOV 28, 2019
Drug Discovery & Development
NOV 28, 2019
Immunotherapy Drug Shows Promise for Treating Advanced Prostate Cancer
By the end of the year, an estimated 175,000 men in the United States will have been diagnosed with prostate cancer. Now, researchers from the UK have foun...
DEC 04, 2019
Immunology
DEC 04, 2019
Predicting Death with Clinical Immune Indicators
Immune and inflammation status could help doctors predict which individuals are most at-risk for death. Results from a new study mark the first step toward...
DEC 20, 2019
Health & Medicine
DEC 20, 2019
A Natural Approach to Pain Management
In many instances, pain can be a rather useful tool. It informs individuals that something is amiss with their body and they should seek treatment. However...
FEB 06, 2020
Drug Discovery & Development
FEB 06, 2020
China Begins Trials for Antiviral Drug to Tackle Coronavirus
So far, coronavirus has infected over 31,493 people globally, and has killed 638. Although 1,563 people have reportedly recovered, due to its fast-spreadin...
FEB 17, 2020
Immunology
FEB 17, 2020
Another HIV vaccine attempt fizzles out
Years of work and over $100 million in study costs have been abandoned after an HIV-vaccine tested in South Africa failed to protect treated individuals ag...
Loading Comments...